tiprankstipranks
Trending News
More News >
InspireMD (NSPR)
NASDAQ:NSPR
US Market

InspireMD (NSPR) Technical Analysis

Compare
688 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
InspireMD’s (NSPR) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting InspireMD is a Sell.
InspireMD’s (NSPR) 20-Day exponential moving average is 2.49, while InspireMD’s (NSPR) share price is $2.5, making it a Buy.
InspireMD’s (NSPR) 50-Day exponential moving average is 2.55, while InspireMD’s (NSPR) share price is $2.5, making it a Sell.

InspireMD (NSPR) Pivot Points

Jun 08, 2025, 04:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.32
2.39
2.45
2.52
2.58
2.65
2.71
Fibonacci
2.39
2.44
2.47
2.52
2.57
2.60
2.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InspireMD (NSPR) Moving Averages

Jun 08, 2025, 04:46 PM
Period
Simple
Exponential
MA5
2.54Sell
2.52Sell
MA10
2.53Sell
2.50Sell
MA20
2.45Buy
2.49Buy
MA50
2.53Sell
2.55Sell
MA100
2.69Sell
2.63Sell
MA200
2.70Sell
2.65Sell
InspireMD’s (NSPR) 10-Day exponential moving average is 2.50, while InspireMD’s (NSPR) share price is $2.5, making it a Sell.
InspireMD’s (NSPR) 100-Day exponential moving average is 2.63, while InspireMD’s (NSPR) share price is $2.5, making it a Sell.
InspireMD’s (NSPR) stock price is $2.5 and InspireMD’s (NSPR) 50-day simple moving average is 2.53, creating a Sell signal.
InspireMD’s (NSPR) stock price is $2.5 and InspireMD’s (NSPR) 100-day simple moving average is 2.69, creating a Sell signal.
InspireMD’s (NSPR) stock price is $2.5 and InspireMD’s (NSPR) 200-day simple moving average is 2.70, creating a Sell signal.

InspireMD (NSPR) Technical Indicators

Jun 08, 2025, 04:46 PM
Name
Value
Implied Action
RSI (14)
50.06
Neutral
STOCH (9,6)
59.85
Neutral
STOCHRSI (14)
76.43
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
16.23
Buy
Williams %R
-30.30
Buy
CCI (14)
29.76
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
52.28
Neutral
ROC
5.93
Buy
InspireMD’s (NSPR) Relative Strength Index (RSI) is 50.06, creating a Neutral signal.
InspireMD’s (NSPR) Trend Strength Indicator (ADX) is 16.23, creating a Buy signal.
InspireMD’s (NSPR) Commodity Channel Index (CCI) is 29.76, creating a Neutral signal.
InspireMD’s (NSPR) Price Rate of Change (ROC) is 5.93, creating a Buy signal.

FAQ

Is NSPR a Buy, Hold, or Sell?
Based on NSPR’s technical indicators, NSPR is a Sell.
    What is NSPR’s RSI (14)?
    NSPR’s RSI (14) is 50.06, which suggests NSPR is a Neutral.
      What is NSPR’s MACD?
      NSPR’s MACD is <0.01, which suggests NSPR is a Sell.
        What is NSPR’s 5-day moving average?
        NSPR’s 5-day moving average is 2.54, which suggests NSPR is a Sell.
          What is NSPR’s 20-day moving average?
          NSPR 20-day moving average is 2.45, which suggests NSPR is a Buy.
            What is NSPR’s 50-day moving average?
            NSPR’s 50-day moving average is 2.53, which suggests NSPR is a Sell.
              What is NSPR’s 200-day moving average?
              NSPR’s 200-day moving average is 2.70, which suggests NSPR is a Sell.
                What is NSPR’s Williams % R (14)?
                NSPR’s Williams % R (14) is -30.30, which suggests NSPR is a Buy.
                  What is NSPR’s CCI (14)?
                  NSPR’s CCI (14) is 29.76, which suggests NSPR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis